POLINA SAMOYLOVA: Open Payments
NPI 1295211159 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,599 in 263 payments from 37 companies in 2025. Trend: 2023 $3,736 · 2024 $4,147 · 2025 $4,599
Food & beverage: $4,500Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $382 |
| UCB, Inc. | 24 | $373 |
| ARGENX US, INC. | 14 | $346 |
| Novartis Pharmaceuticals Corporation | 21 | $294 |
| Eisai Inc. | 18 | $270 |
| Lundbeck LLC | 25 | $265 |
| Biogen, Inc. | 19 | $242 |
| Lilly USA, LLC | 12 | $208 |
| Alexion Pharmaceuticals, Inc. | 9 | $208 |
| Otsuka America Pharmaceutical, Inc. | 6 | $205 |
Products named: VYVGART HYTRULO, REXULTI, KESIMPTA, Leqembi, TYSABRI, ULTOMIRIS, Rystiggo, KISUNLA.
Industry payments across AZ — which companies pay providers there.
